XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating activities    
Profit (loss) from continuing operations $ 97.5 $ (36.4)
Adjustments for:    
Depreciation expense 221.7 242.0
Deferred revenue recognized 0.0 (195.0)
Impairment charge 0.0 17.1
Income tax expense 30.7 78.1
Derivative gain (22.9) (21.9)
Write-down of inventories 5.9 1.3
Finance costs 21.0 8.6
Other non-cash items (10.0) 15.8
Adjustments for cash items:    
Proceeds from gold prepayment 0.0 236.0
Proceeds from insurance claim 0.6 1.2
Settlement of derivatives 23.3 20.9
Disbursements related to asset retirement obligations (2.0) (2.0)
Movements in non-cash working capital items and non-current ore stockpiles (14.9) (40.6)
Cash from operating activities, before income taxes paid 226.3 325.1
Income taxes paid (82.3) (67.5)
Net cash from operating activities related to continuing operations 144.0 257.6
Net cash from operating activities related to discontinued operations 15.4 151.1
Net cash from operating activities 159.4 408.7
Investing activities    
Capital expenditures for property, plant and equipment (907.3) (742.7)
Capitalized borrowing costs (68.3) (37.8)
Disposal of marketable securities (net) (0.4) 27.6
Other investing activities (4.9) (8.3)
Net cash used in investing activities related to continuing operations (394.1) (761.2)
Net cash used in investing activities related to discontinued operations (8.2) (130.7)
Net cash used in investing activities (402.3) (891.9)
Financing activities    
Common shares issued for cash on exercise of stock options 327.1 0.0
Dividends paid to non-controlling interests (13.7) (18.4)
Other financing activities (33.7) (15.7)
Net cash from financing activities related to continuing operations 203.7 420.9
Net cash used in financing activities related to discontinued operations (2.0) (16.9)
Net cash from financing activities 201.7 404.0
Effects of exchange rate fluctuation on cash and cash equivalents 1.3 (17.1)
Decrease in cash and cash equivalents - all operations (39.9) (96.3)
Decrease in cash and cash equivalents - held for sale (0.8) (40.8)
Decrease in cash and cash equivalents - continuing operations (40.7) (137.1)
Cash and cash equivalents, beginning of the year 407.8 544.9
Cash and cash equivalents, end of the year 367.1 407.8
Bambouk    
Adjustments for:    
Gain on sale of joint ventures (109.1) 0.0
Investing activities    
Proceeds from sale of joint ventures 197.6 0.0
Rosebel    
Investing activities    
Proceeds from sale of joint ventures 389.2 0.0
Pitangui and Acurui Projects    
Adjustments for:    
Gain on sale of joint ventures (15.5) 0.0
Credit Facility    
Financing activities    
Proceeds from (repayment of) credit facility (455.0) 455.0
Equipment loans    
Financing activities    
Proceeds from borrowings $ 379.0 $ 0.0